Mucormycosis of the Central Nervous System
AbstractMucormycosis involves the central nervous system by direct extension from infected paranasal sinuses or hematogenous dissemination from the lungs. Incidence rates of this rare disease seem to be rising, with a shift from the rhino-orbital-cerebral syndrome typical of patients with diabetes mellitus and ketoacidosis, to disseminated disease in patients with hematological malignancies. We present our current understanding of the pathobiology, clinical features, and diagnostic and treatment strategies of cerebral mucormycosis. Despite advances in imaging and the availability of novel drugs, cerebral mucormycosis continues to be associated with high rates of death and disability. Emerging molecular diagnostics, advances in experimental systems and the establishment of large patient registries are key components of ongoing efforts to provide a timely diagnosis and effective treatment to patients with cerebral mucormycosis. View Full-Text
Share & Cite This Article
Chikley, A.; Ben-Ami, R.; Kontoyiannis, D.P. Mucormycosis of the Central Nervous System. J. Fungi 2019, 5, 59.
Chikley A, Ben-Ami R, Kontoyiannis DP. Mucormycosis of the Central Nervous System. Journal of Fungi. 2019; 5(3):59.Chicago/Turabian Style
Chikley, Amanda; Ben-Ami, Ronen; Kontoyiannis, Dimitrios P. 2019. "Mucormycosis of the Central Nervous System." J. Fungi 5, no. 3: 59.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.